New pneumonia vaccine candidate enters human safety testing

NCT ID NCT07168915

First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 30 times

Summary

This study tests a new vaccine called V118E that aims to prevent diseases caused by Streptococcus pneumoniae bacteria, such as pneumonia. Researchers want to see if the vaccine is safe and well-tolerated in 126 healthy adults. Participants will receive either the new vaccine or a licensed vaccine (Prevnar 20) and be monitored for side effects and immune response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0004)

    RECRUITING

    Springfield, Missouri, 65802, United States

    Contact Phone: •••-•••-••••

  • QPS-MRA, LLC-Early Phase ( Site 0002)

    RECRUITING

    South Miami, Florida, 33143, United States

    Contact Phone: •••-•••-••••

  • University of Texas Medical Branch ( Site 0001)

    RECRUITING

    Galveston, Texas, 77555-1115, United States

    Contact Phone: •••-•••-••••

  • Velocity Clinical Research, Hallandale Beach ( Site 0003)

    RECRUITING

    Hallandale, Florida, 33009, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.